FDA Orange Book
Is there a generic for Voydeya?
Voydeya contains danicopan. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Voydeya (danicopan). The Orange Book shows its last listed patent expires August 2, 2038 and its last listed exclusivity ends March 29, 2031.
Run it in Rivvi
Map Voydeya and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Voydeya products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, oral | 100MG | Marketed (Rx) | None | 0 | None |
| tablet, oral | 50MG | Marketed (Rx) | None | 0 | None |
NDA 218037, held by ALEXION PHARMACEUTICALS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Voydeya patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 9796741 | March 29, 2038 | Drug substance | U-3933 | 218037 |
| 12076319 | August 2, 2038 | Method of use | U-3933 | 218037 |
Voydeya exclusivity
| Code | Meaning | Expires | NDA |
|---|---|---|---|
| NCE | New chemical entity | March 29, 2029 | 218037 |
| ODE-476 | Orphan drug exclusivity | March 29, 2031 | 218037 |
Voydeya NDC codes
Questions
Is there a generic for Voydeya?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Voydeya (danicopan). The Orange Book shows its last listed patent expires August 2, 2038 and its last listed exclusivity ends March 29, 2031.
What is the generic name for Voydeya?
The active ingredient in Voydeya is danicopan, per the FDA Orange Book.
When does the Voydeya patent expire?
The last patent listed for Voydeya in the Orange Book expires August 2, 2038. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.